Abstract:
Objective:To clarify the effects of the BMP receptor inhibitor LDN-193189 in the dedifferentiated chondrosarcoma (DDCS) cell line NDCS-1 and to explore the anti-tumor mechanism of LDN- 193189 in DDCS. Methods: NDCS-1 was treated with 5 nmol/L of LDN- 193189 . MTT assay and clone formation experiments were used to verify that LDN- 193189 suppressed cell proliferation. Transwell and wound healing tests were performed to demonstrate that LDN-193189 inhibited cell invasion. Western blot detection was used to show that LDN- 193189 inhibited the suppression of BMPR 2, p-Smad 1/5, and RUNX 2 protein expression. Results:The BMPR2 signaling pathway was inhibited by LDN- 193189 ; thus, cell viability and invasion were significantly suppressed. Conclusion: LDN- 193189 induces the inhibition of progression in vitro via the BMPR2-p-Smad 1/5-RUNX 2 signaling pathway in the human DDCS cell line NDCS- 1.